Stroke RSS Page 15

Filtered By:
Source: Thrombosis and Haemostasis

This page shows you your search results in order of date. This is page number 15.

Order by Relevance | Date

Total 528 results found since Jan 2013.

Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD-AF Registry
CONCLUSIONS: Patients who discontinued (n=3,114, 13.0%) had a higher risk (Hazard ratio [95% CI]) of all-cause death (1.62 [1.25-2.09]), stroke/systemic embolism (SE) (2.21 [1.42-3.44]) and myocardial infarction (MI) (1.85 [1.09-3.13]) than patients who did not, whether OAC was restarted or not. This higher risk of outcomes after discontinuation was similar for patients treated with vitamin K antagonists (VKA) and direct oral anticoagulants (DOACs) (p for interactions range=0.145-0.778). Bleeding history (1.43 [1.14-1.80]), paroxysmal vs. persistent AF (1.15 [1.02-1.29]), emergency room care setting vs. office (1.37 [1.18-...
Source: Thrombosis and Haemostasis - June 1, 2021 Category: Hematology Authors: Frank Cools Dana Johnson A John Camm Jean-Pierre Bassand Freek W A Verheugt Shu Yang Anastasios Tsiatis David A Fitzmaurice Samuel Z Goldhaber Gloria Kayani Shinya Goto Sylvia Haas Frank Misselwitz Alexander G G Turpie Keith A A Fox Karen S Pieper Ajay K Source Type: research

Adherence to the 'Atrial Fibrillation Better Care' (ABC) Pathway in Patients with Atrial Fibrillation
CONCLUSION: Adherence to the ABC pathway was suboptimal, being adopted in 1 in every 5 patients. Adherence to the ABC pathway was associated with a reduction in the risk of major adverse outcomes.PMID:34020488 | DOI:10.1055/a-1515-9630
Source: Thrombosis and Haemostasis - May 21, 2021 Category: Hematology Authors: Giulio Francesco Romiti Daniele Pastori Jos é Miguel Rivera-Caravaca Wern Yew Ding Ying X Gue Danilo Menichelli Jakub Gumprecht Monika Koziel Pil-Sung Yang Yutao Guo Gregory Yh Lip Marco Proietti Source Type: research

Subclinical Atrial Fibrillation and the Risk of Recurrent Ischemic Stroke
Thromb Haemost. 2021 May 21. doi: 10.1055/s-0041-1726403. Online ahead of print.NO ABSTRACTPMID:34020463 | DOI:10.1055/s-0041-1726403
Source: Thrombosis and Haemostasis - May 21, 2021 Category: Hematology Authors: Rolf Wachter Ben Freedman Source Type: research

Optimal tests to minimise bleeding and ischaemic complications in patients on short-term mechanical circulatory support
Thromb Haemost. 2021 May 13. doi: 10.1055/a-1508-8230. Online ahead of print.ABSTRACTPatients receiving left-sided mechanical circulatory support (MCS) require systemic anticoagulation with unfractionated heparin (UFH) to prevent clotting of the circuit and reduce the risk of arterial thrombosis. With MCS, there is a very high frequency of bleeding and ischaemic complications, including stroke and systemic embolism. Monitoring of UFH can be very challenging. Whilst most centres routinely monitor the activated clotting time, prothrombin time, activated partial thromboplastin time (aPTT) and fibrinogen to assess haemostasis,...
Source: Thrombosis and Haemostasis - May 13, 2021 Category: Hematology Authors: Rahim Kanji Christophe Vandenbriele Deepa Arachchillage Susanna Price Diana Adrienne Gorog Source Type: research

A new paradigm of 'real time' stroke risk prediction and integrated care management in the digital health era
Thromb Haemost. 2021 May 13. doi: 10.1055/a-1508-7980. Online ahead of print.ABSTRACTNo Abstract.PMID:33984864 | DOI:10.1055/a-1508-7980
Source: Thrombosis and Haemostasis - May 13, 2021 Category: Hematology Authors: Yutao Guo Source Type: research

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20